A small unscientific investigation into how we value and compare ourselves to each other

The first half of this conversation is a searingly honest account of...

Members of Congress love buying and selling stocks. Insider's weekly congressional financial report details how lawmakers invest and make money.

C++ Software Security Sins   In the world of software development, we are up against new cybersecurity threats each day, and the risks and consequences of un-secure software are too significant to be unaware of.
Let’s review some common security threats…

The SARS-CoV-2 pandemic introduced the world to a new type of vaccine based on mRNA encapsulated in lipid nanoparticles (LNPs). Instead of delivering antigenic proteins directly, an mRNA-based vaccine relies on the host's cells to manufacture protein immunogens…

When reasonable people stay silent, the voices of the unreasonable are allowed infinite room to fill the void.

Learn more about ResearchHub, our mission, and the team behind the platform.

Last week I was in San Francisco, one of the most beautiful cities in the world on a video shoot for Kelby One on Crissy Field — one of the premier spots in town — at the foot of the majestic Golden Gate Bridge when one of my cameras was stolen right in front…

The deep sea is a part of our planet unlike any other. Accounting for over 95 percent of Earth’s living space, it is cold, dark, and under extreme pressure, yet...

A new Firefox is coming your way on June 1 with a fresh look designed for today’s modern life online. We pored over the browser’s user interface pixel

In regards to the Belarus Forces Down Plane to Seize Dissident; Europe Sees ‘State Hijacking’ I wonder if the Belarus intelligence was handed the manifest as a routine or they somehow got access th...

An unexpected paradigm journey into sleep sort

Major publishers want to censor research-sharing resource Sci-Hub from the internet, but archivists quickly respond to make that impossible. More than half of academic publishing is controlled by

In France, more towns and cities are introducing different forms of free public transport. But could fare-free policies ever be rolled out to major cities like Paris?

Moderna will take mRNA flu and HIV vaccines into Phase 1 trials this year, as well as beginning a pivotal Phase 3 study for its cytomegalovirus (CMV) vaccine candidate.